145 related articles for article (PubMed ID: 31912680)
21. Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a population-based analysis.
Zhou J; Wu SG; Sun JY; Li FY; Lin HX; Chen QH; He ZY
J Cancer Res Clin Oncol; 2017 Jan; 143(1):115-122. PubMed ID: 27646608
[TBL] [Abstract][Full Text] [Related]
22. A Real-World Study on Diagnosis and Treatment of Uterine Sarcoma in Western China.
Li D; Yin N; Du G; Wang S; Xiao Z; Chen J; Chen W
Int J Biol Sci; 2020; 16(3):388-395. PubMed ID: 32015676
[TBL] [Abstract][Full Text] [Related]
23. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
[TBL] [Abstract][Full Text] [Related]
24. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
[TBL] [Abstract][Full Text] [Related]
25. Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma.
Jain V; Venigalla S; Sebro RA; Karakousis GC; Wilson RJ; Weber KL; Shabason JE
Cancer Med; 2019 Oct; 8(14):6295-6304. PubMed ID: 31483578
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Treatment of Recurrent Uterine Sarcoma.
Díaz-Montes TP; El-Sharkawy F; Lynam S; Harper A; Sittig M; MacDonald R; Gushchin V; Sardi A
Int J Gynecol Cancer; 2018 Jul; 28(6):1130-1137. PubMed ID: 29975291
[TBL] [Abstract][Full Text] [Related]
27. Survival of Patients With Non-Rhabdomyosarcoma Soft Tissue Sarcomas of the Head and Neck.
Rastatter JC; Sinard RN; Dilger A; Reichek J; Walterhouse DO; Patel U
Laryngoscope; 2021 Feb; 131(2):E500-E508. PubMed ID: 32531087
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis and treatment of sarcoma of the uterus. A review.
Tropé CG; Abeler VM; Kristensen GB
Acta Oncol; 2012 Jul; 51(6):694-705. PubMed ID: 22793037
[TBL] [Abstract][Full Text] [Related]
29. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
Mikami Y; Hata S; Kiyokawa T; Manabe T
Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
[TBL] [Abstract][Full Text] [Related]
30. Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998.
Livi L; Andreopoulou E; Shah N; Paiar F; Blake P; Judson I; Harmer C
Clin Oncol (R Coll Radiol); 2004 Jun; 16(4):261-8. PubMed ID: 15214650
[TBL] [Abstract][Full Text] [Related]
31. [Clinicopathologic characteristics and prognosis factors of uterine sarcomas in central Tunisia].
Khlifi A; Fathallah K; Zbidi C; Hidar S; Bibi M; Khairi H
Bull Cancer; 2014; 101(7-8):669-80. PubMed ID: 25091649
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of parity in 493 uterine sarcoma patients.
Albrektsen G; Heuch I; Wik E; Salvesen HB
Int J Gynecol Cancer; 2009 Aug; 19(6):1062-7. PubMed ID: 19820369
[TBL] [Abstract][Full Text] [Related]
33. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the relationship between adenosarcoma and carcinosarcoma and a hypothesis of the histogenesis of uterine sarcomas.
Seidman JD; Chauhan S
Int J Gynecol Pathol; 2003 Jan; 22(1):75-82. PubMed ID: 12496702
[TBL] [Abstract][Full Text] [Related]
35. The role of adjuvant radiation in uterine sarcomas.
Sampath S; Schultheiss TE; Ryu JK; Wong JY
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):728-34. PubMed ID: 19700247
[TBL] [Abstract][Full Text] [Related]
36. Uterine sarcoma in the south of Israel: study of 36 cases.
Piura B; Rabinovich A; Yanai-Inbar I; Cohen Y; Glezerman M
J Surg Oncol; 1997 Jan; 64(1):55-62. PubMed ID: 9040802
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of treatment results and prognostic factors of uterine sarcoma: A single-center experience.
Momtahan M; Emami F; Sari Aslani F; Akbarzadeh-Jahromi M
J Chin Med Assoc; 2020 Jan; 83(1):84-88. PubMed ID: 31517774
[TBL] [Abstract][Full Text] [Related]
38. Patterns of Radiotherapy Use and Outcomes in Head and Neck Soft-Tissue Sarcoma in a National Cohort.
Kim JK; Verma N; McBride S; Riaz N; Boyle JO; Spielsinger D; Sabol C; Waldenberg T; Brinkman T; Alektiar K; Lee NY; Tsai CJ
Laryngoscope; 2020 Jan; 130(1):120-127. PubMed ID: 30892716
[TBL] [Abstract][Full Text] [Related]
39. Demographics, stage distribution, and relative roles of surgery and radiotherapy on survival of persons with primary prostate sarcomas.
Tward JD; Poppe MM; Hitchcock YJ; O'Neil B; Albertson DJ; Shrieve DC
Cancer Med; 2018 Dec; 7(12):6030-6039. PubMed ID: 30453392
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis, treatment and survival of uterine sarcoma: A retrospective cohort study of 122 cases.
Plentz TBSF; Candido EC; Dias LF; Toledo MCS; Vale DB; Teixeira JC
Mol Clin Oncol; 2020 Dec; 13(6):81. PubMed ID: 33093955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
